1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031) 2.1.2 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031) 2.1.3 World Current & Future Analysis for Placental Stem Cell Therapy for Neurological Disorders by Country/Region (2020, 2024 & 2031) 2.2 Placental Stem Cell Therapy for Neurological Disorders Segment by Type 2.2.1 Allogeneic Placental Stem Cell Therapy 2.2.2 Autologous Placental Stem Cell Therapy 2.3 Placental Stem Cell Therapy for Neurological Disorders Market Size by Type 2.3.1 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031) 2.3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2020-2025) 2.4 Placental Stem Cell Therapy for Neurological Disorders Segment by Application 2.4.1 Hospitals and Specialist Clinics 2.4.2 Clinical Research Institute 2.5 Placental Stem Cell Therapy for Neurological Disorders Market Size by Application 2.5.1 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031) 2.5.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2020-2025) 3 Placental Stem Cell Therapy for Neurological Disorders Market Size by Player 3.1 Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Player 3.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Player (2020-2025) 3.1.2 Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player (2020-2025) 3.2 Global Placental Stem Cell Therapy for Neurological Disorders Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Placental Stem Cell Therapy for Neurological Disorders by Region 4.1 Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) 4.2 Global Placental Stem Cell Therapy for Neurological Disorders Annual Revenue by Country/Region (2020-2025) 4.3 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2020-2025) 4.4 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2020-2025) 4.5 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2020-2025) 4.6 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2020-2025) 5 Americas 5.1 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) 5.2 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) 5.3 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) 6.2 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) 6.3 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) 7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) 7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders by Region (2020-2025) 8.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) 8.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Placental Stem Cell Therapy for Neurological Disorders Market Forecast 10.1 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2026-2031) 10.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2026-2031) 10.1.2 Americas Placental Stem Cell Therapy for Neurological Disorders Forecast 10.1.3 APAC Placental Stem Cell Therapy for Neurological Disorders Forecast 10.1.4 Europe Placental Stem Cell Therapy for Neurological Disorders Forecast 10.1.5 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Forecast 10.2 Americas Placental Stem Cell Therapy for Neurological Disorders Forecast by Country (2026-2031) 10.2.1 United States Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.2.2 Canada Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.2.3 Mexico Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.2.4 Brazil Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.3 APAC Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2026-2031) 10.3.1 China Placental Stem Cell Therapy for Neurological Disorders Market Forecast 10.3.2 Japan Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.3.3 Korea Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.3.4 Southeast Asia Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.3.5 India Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.3.6 Australia Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.4 Europe Placental Stem Cell Therapy for Neurological Disorders Forecast by Country (2026-2031) 10.4.1 Germany Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.4.2 France Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.4.3 UK Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.4.4 Italy Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.4.5 Russia Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.5 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2026-2031) 10.5.1 Egypt Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.5.2 South Africa Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.5.3 Israel Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.5.4 Turkey Market Placental Stem Cell Therapy for Neurological Disorders Forecast 10.6 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Type (2026-2031) 10.7 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Application (2026-2031) 10.7.1 GCC Countries Market Placental Stem Cell Therapy for Neurological Disorders Forecast 11 Key Players Analysis 11.1 Mesoblast 11.1.1 Mesoblast Company Information 11.1.2 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.1.4 Mesoblast Main Business Overview 11.1.5 Mesoblast Latest Developments 11.2 Pleurite Therapeutic 11.2.1 Pleurite Therapeutic Company Information 11.2.2 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.2.4 Pleurite Therapeutic Main Business Overview 11.2.5 Pleurite Therapeutic Latest Developments 11.3 Athersys 11.3.1 Athersys Company Information 11.3.2 Athersys Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.3.4 Athersys Main Business Overview 11.3.5 Athersys Latest Developments 11.4 Cordlife India 11.4.1 Cordlife India Company Information 11.4.2 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.4.4 Cordlife India Main Business Overview 11.4.5 Cordlife India Latest Developments 11.5 Life Cell 11.5.1 Life Cell Company Information 11.5.2 Life Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.5.4 Life Cell Main Business Overview 11.5.5 Life Cell Latest Developments 11.6 Cryo-Cell 11.6.1 Cryo-Cell Company Information 11.6.2 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.6.4 Cryo-Cell Main Business Overview 11.6.5 Cryo-Cell Latest Developments 11.7 CBR Systems 11.7.1 CBR Systems Company Information 11.7.2 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.7.4 CBR Systems Main Business Overview 11.7.5 CBR Systems Latest Developments 11.8 ReNeuron Group 11.8.1 ReNeuron Group Company Information 11.8.2 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.8.4 ReNeuron Group Main Business Overview 11.8.5 ReNeuron Group Latest Developments 11.9 Cynata 11.9.1 Cynata Company Information 11.9.2 Cynata Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.9.4 Cynata Main Business Overview 11.9.5 Cynata Latest Developments 11.10 Celularity 11.10.1 Celularity Company Information 11.10.2 Celularity Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.10.4 Celularity Main Business Overview 11.10.5 Celularity Latest Developments 11.11 Americord Registry 11.11.1 Americord Registry Company Information 11.11.2 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.11.4 Americord Registry Main Business Overview 11.11.5 Americord Registry Latest Developments 11.12 ReeLabs 11.12.1 ReeLabs Company Information 11.12.2 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.12.4 ReeLabs Main Business Overview 11.12.5 ReeLabs Latest Developments 11.13 Mesoblast 11.13.1 Mesoblast Company Information 11.13.2 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered 11.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2020-2025) 11.13.4 Mesoblast Main Business Overview 11.13.5 Mesoblast Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions) Table 2. Placental Stem Cell Therapy for Neurological Disorders Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Allogeneic Placental Stem Cell Therapy Table 4. Major Players of Autologous Placental Stem Cell Therapy Table 5. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions) Table 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) & ($ millions) Table 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2020-2025) Table 8. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions) Table 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) & ($ millions) Table 10. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2020-2025) Table 11. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Player (2020-2025) & ($ millions) Table 12. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player (2020-2025) Table 13. Placental Stem Cell Therapy for Neurological Disorders Key Players Head office and Products Offered Table 14. Placental Stem Cell Therapy for Neurological Disorders Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & ($ millions) Table 18. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2020-2025) Table 19. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Country/Region (2020-2025) & ($ millions) Table 20. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Country/Region (2020-2025) Table 21. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & ($ millions) Table 22. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country (2020-2025) Table 23. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) & ($ millions) Table 24. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2020-2025) Table 25. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) & ($ millions) Table 26. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2020-2025) Table 27. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & ($ millions) Table 28. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2020-2025) Table 29. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) & ($ millions) Table 30. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) & ($ millions) Table 31. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & ($ millions) Table 32. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country (2020-2025) Table 33. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) & ($ millions) Table 34. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) & ($ millions) Table 35. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & ($ millions) Table 36. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) & ($ millions) Table 37. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) & ($ millions) Table 38. Key Market Drivers & Growth Opportunities of Placental Stem Cell Therapy for Neurological Disorders Table 39. Key Market Challenges & Risks of Placental Stem Cell Therapy for Neurological Disorders Table 40. Key Industry Trends of Placental Stem Cell Therapy for Neurological Disorders Table 41. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Region (2026-2031) & ($ millions) Table 42. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Region (2026-2031) Table 43. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Type (2026-2031) & ($ millions) Table 44. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Application (2026-2031) & ($ millions) Table 45. Mesoblast Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 46. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 47. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 48. Mesoblast Main Business Table 49. Mesoblast Latest Developments Table 50. Pleurite Therapeutic Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 51. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 52. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 53. Pleurite Therapeutic Main Business Table 54. Pleurite Therapeutic Latest Developments Table 55. Athersys Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 56. Athersys Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 57. Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 58. Athersys Main Business Table 59. Athersys Latest Developments Table 60. Cordlife India Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 61. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 62. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 63. Cordlife India Main Business Table 64. Cordlife India Latest Developments Table 65. Life Cell Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 66. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 67. Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 68. Life Cell Main Business Table 69. Life Cell Latest Developments Table 70. Cryo-Cell Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 71. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 72. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 73. Cryo-Cell Main Business Table 74. Cryo-Cell Latest Developments Table 75. CBR Systems Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 76. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 77. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 78. CBR Systems Main Business Table 79. CBR Systems Latest Developments Table 80. ReNeuron Group Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 81. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 82. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 83. ReNeuron Group Main Business Table 84. ReNeuron Group Latest Developments Table 85. Cynata Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 86. Cynata Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 87. Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 88. Cynata Main Business Table 89. Cynata Latest Developments Table 90. Celularity Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 91. Celularity Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 92. Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 93. Celularity Main Business Table 94. Celularity Latest Developments Table 95. Americord Registry Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 96. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 97. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 98. Americord Registry Main Business Table 99. Americord Registry Latest Developments Table 100. ReeLabs Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 101. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 102. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 103. ReeLabs Main Business Table 104. ReeLabs Latest Developments Table 105. Mesoblast Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors Table 106. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered Table 107. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 108. Mesoblast Main Business Table 109. Mesoblast Latest Developments List of Figures Figure 1. Placental Stem Cell Therapy for Neurological Disorders Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate (2020-2031) ($ millions) Figure 6. Placental Stem Cell Therapy for Neurological Disorders Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 7. Placental Stem Cell Therapy for Neurological Disorders Sales Market Share by Country/Region (2024) Figure 8. Placental Stem Cell Therapy for Neurological Disorders Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type in 2024 Figure 10. Placental Stem Cell Therapy for Neurological Disorders in Hospitals and Specialist Clinics Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Market: Hospitals and Specialist Clinics (2020-2025) & ($ millions) Figure 12. Placental Stem Cell Therapy for Neurological Disorders in Clinical Research Institute Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Market: Clinical Research Institute (2020-2025) & ($ millions) Figure 14. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application in 2024 Figure 15. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player in 2024 Figure 16. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2020-2025) Figure 17. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size 2020-2025 ($ millions) Figure 18. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size 2020-2025 ($ millions) Figure 19. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size 2020-2025 ($ millions) Figure 20. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2020-2025 ($ millions) Figure 21. Americas Placental Stem Cell Therapy for Neurological Disorders Value Market Share by Country in 2024 Figure 22. United States Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 23. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 24. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 25. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 26. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region in 2024 Figure 27. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2020-2025) Figure 28. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2020-2025) Figure 29. China Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 30. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 31. South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 32. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 33. India Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 34. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 35. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country in 2024 Figure 36. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2020-2025) Figure 37. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2020-2025) Figure 38. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 39. France Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 40. UK Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 41. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 42. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 43. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2020-2025) Figure 44. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2020-2025) Figure 45. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2020-2025) Figure 46. Egypt Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 47. South Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 48. Israel Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 49. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 50. GCC Countries Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2020-2025 ($ millions) Figure 51. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 52. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 53. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 54. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 55. United States Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 56. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 57. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 58. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 59. China Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 60. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 61. Korea Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 62. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 63. India Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 64. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 65. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 66. France Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 67. UK Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 68. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 69. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 70. Egypt Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 71. South Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 72. Israel Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 73. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions) Figure 74. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Type (2026-2031) Figure 75. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Application (2026-2031) Figure 76. GCC Countries Placental Stem Cell Therapy for Neurological Disorders Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Mesoblast|||Pleurite Therapeutic|||Athersys|||Cordlife India|||Life Cell|||Cryo-Cell|||CBR Systems|||ReNeuron Group|||Cynata|||Celularity|||Americord Registry|||ReeLabs